Amneal Pharmaceuticals Inc, a company engaged in the development, manufacture, and distribution of generic and specialty pharmaceutical products, has seen a notable insider transaction trend.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Has Amneal Pharmaceuticals (AMRX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer ...
JP Morgan has recently raised Amneal Pharmaceuticals Inc (AMRX) stock to Neutral rating, as announced on September 6, 2024, according to Finviz. Earlier, on April 7, 2021, RBC Capital Mkts had resumed ...
Lupin has partnered with Scope Ophthalmics to market a range of eyecare products in Mexico, including products for dry eyes, blepharitis, and MGD. Sep 30, 2024 17:54 Gland Pharma Q1 Profit Down 26% to ...
Tata-owned Starbucks has become the largest organised café operator in India with 457 stores across 70 cities. This milestone follows the addition of 19 new outlets in five new cities in Q2 FY25. Tata ...